Literature DB >> 18085398

What does the circulating AHSG/fetuin-A level tell us?

Junichiro James Kazama1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18085398     DOI: 10.1007/s10157-007-0513-4

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


× No keyword cloud information.
  11 in total

1.  The serum protein alpha2-HS glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. A possible role in mineralization and calcium homeostasis.

Authors:  T Schinke; C Amendt; A Trindl; O Pöschke; W Müller-Esterl; W Jahnen-Dechent
Journal:  J Biol Chem       Date:  1996-08-23       Impact factor: 5.157

2.  The immunohistochemical localization of alpha2-Heremans-Schmid glycoprotein/fetuin-A (AHSG).

Authors:  Junichiro J Kazama; Fumitake Gejyo; Isei Ei
Journal:  Nephrol Dial Transplant       Date:  2005-04       Impact factor: 5.992

3.  Purification and characterization of the two forms of human plasma alpha 2HS-glycoprotein.

Authors:  F Gejyo; K Schmid
Journal:  Biochim Biophys Acta       Date:  1981-11-30

4.  Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study.

Authors:  Markus Ketteler; Philipp Bongartz; Ralf Westenfeld; Joachim Ernst Wildberger; Andreas Horst Mahnken; Roland Böhm; Thomas Metzger; Christoph Wanner; Willi Jahnen-Dechent; Jürgen Floege
Journal:  Lancet       Date:  2003-03-08       Impact factor: 79.321

5.  Alpha 2HS-glycoprotein in the serum and urine of patients with renal diseases.

Authors:  B K Kishore; F Gejyo; M Arakawa
Journal:  Postgrad Med J       Date:  1983-05       Impact factor: 2.401

6.  Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease: data from the Heart and Soul Study.

Authors:  Joachim H Ix; Glenn M Chertow; Michael G Shlipak; Vincent M Brandenburg; Markus Ketteler; Mary A Whooley
Journal:  Circulation       Date:  2007-05-07       Impact factor: 29.690

7.  The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification.

Authors:  Cora Schafer; Alexander Heiss; Anke Schwarz; Ralf Westenfeld; Markus Ketteler; Jurgen Floege; Werner Muller-Esterl; Thorsten Schinke; Willi Jahnen-Dechent
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

8.  Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles.

Authors:  Alexander Heiss; Alexander DuChesne; Bernd Denecke; Joachim Grötzinger; Kazuhiko Yamamoto; Thomas Renné; Willi Jahnen-Dechent
Journal:  J Biol Chem       Date:  2003-01-29       Impact factor: 5.157

9.  Noncollagenous proteins in normal and pathological human bone.

Authors:  K J Quelch; W G Cole; R A Melick
Journal:  Calcif Tissue Int       Date:  1984-09       Impact factor: 4.333

10.  Evaluation of serum fetuin-A relationships with biochemical parameters in patients on hemodialysis.

Authors:  Osamu Oikawa; Terumi Higuchi; Toshio Yamazaki; Chii Yamamoto; Noboru Fukuda; Koichi Matsumoto
Journal:  Clin Exp Nephrol       Date:  2007-12-21       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.